Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.

Tobacco use is associated with an increased prevalence of cardiovascular disease. N-terminal pro-brain natiuretic peptide (NT-proBNP), a widely available biomarker that is associated with cardiovascular outcomes in other conditions, has not been investigated as a predictor of mortality in tobacco sm...

Full description

Bibliographic Details
Main Authors: Jason A Stamm, Elizabeth A Belloli, Yingze Zhang, Jessica Bon, Frank C Sciurba, Mark T Gladwin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3210169?pdf=render
id doaj-68d663796d444f20a9d9dbbb987a1282
record_format Article
spelling doaj-68d663796d444f20a9d9dbbb987a12822020-11-24T22:06:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01611e2741610.1371/journal.pone.0027416Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.Jason A StammElizabeth A BelloliYingze ZhangJessica BonFrank C SciurbaMark T GladwinTobacco use is associated with an increased prevalence of cardiovascular disease. N-terminal pro-brain natiuretic peptide (NT-proBNP), a widely available biomarker that is associated with cardiovascular outcomes in other conditions, has not been investigated as a predictor of mortality in tobacco smokers. We hypothesized that NT-proBNP would be an independent prognostic marker in a cohort of well-characterized tobacco smokers without known cardiovascular disease.Clinical data from 796 subjects enrolled in two prospective tobacco exposed cohorts was assessed to determine factors associated with elevated NT-proBNP and the relationship of these factors and NT-proBNP with mortality.Subjects were followed for a median of 562 (IQR 252-826) days. Characteristics associated with a NT-proBNP above the median (≥49 pg/mL) were increased age, female gender, and decreased body mass index. By time-to-event analysis, an NT-proBNP above the median (≥49 pg/mL) was a significant predictor of mortality (log rank p = 0.02). By proportional hazard analysis controlling for age, gender, cohort, and severity of airflow obstruction, an elevated NT-proBNP level (≥49 pg/mL) remained an independent predictor of mortality (HR = 2.19, 95% CI 1.07-4.46, p = 0.031).Elevated NT-proBNP is an independent predictor of mortality in tobacco smokers without known cardiovascular disease, conferring a 2.2 fold increased risk of death. Future studies should assess the ability of this biomarker to guide further diagnostic testing and to direct specific cardiovascular risk reduction inventions that may positively impact quality of life and survival.http://europepmc.org/articles/PMC3210169?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jason A Stamm
Elizabeth A Belloli
Yingze Zhang
Jessica Bon
Frank C Sciurba
Mark T Gladwin
spellingShingle Jason A Stamm
Elizabeth A Belloli
Yingze Zhang
Jessica Bon
Frank C Sciurba
Mark T Gladwin
Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
PLoS ONE
author_facet Jason A Stamm
Elizabeth A Belloli
Yingze Zhang
Jessica Bon
Frank C Sciurba
Mark T Gladwin
author_sort Jason A Stamm
title Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
title_short Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
title_full Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
title_fullStr Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
title_full_unstemmed Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
title_sort elevated n-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Tobacco use is associated with an increased prevalence of cardiovascular disease. N-terminal pro-brain natiuretic peptide (NT-proBNP), a widely available biomarker that is associated with cardiovascular outcomes in other conditions, has not been investigated as a predictor of mortality in tobacco smokers. We hypothesized that NT-proBNP would be an independent prognostic marker in a cohort of well-characterized tobacco smokers without known cardiovascular disease.Clinical data from 796 subjects enrolled in two prospective tobacco exposed cohorts was assessed to determine factors associated with elevated NT-proBNP and the relationship of these factors and NT-proBNP with mortality.Subjects were followed for a median of 562 (IQR 252-826) days. Characteristics associated with a NT-proBNP above the median (≥49 pg/mL) were increased age, female gender, and decreased body mass index. By time-to-event analysis, an NT-proBNP above the median (≥49 pg/mL) was a significant predictor of mortality (log rank p = 0.02). By proportional hazard analysis controlling for age, gender, cohort, and severity of airflow obstruction, an elevated NT-proBNP level (≥49 pg/mL) remained an independent predictor of mortality (HR = 2.19, 95% CI 1.07-4.46, p = 0.031).Elevated NT-proBNP is an independent predictor of mortality in tobacco smokers without known cardiovascular disease, conferring a 2.2 fold increased risk of death. Future studies should assess the ability of this biomarker to guide further diagnostic testing and to direct specific cardiovascular risk reduction inventions that may positively impact quality of life and survival.
url http://europepmc.org/articles/PMC3210169?pdf=render
work_keys_str_mv AT jasonastamm elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
AT elizabethabelloli elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
AT yingzezhang elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
AT jessicabon elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
AT frankcsciurba elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
AT marktgladwin elevatednterminalprobrainnatriureticpeptideisassociatedwithmortalityintobaccosmokersindependentofairflowobstruction
_version_ 1725821526434906112